Compound 1-31 - Compound Search

[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-di(piperidin-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate CAS 13529-31-2 PubChem CID 14029441

CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1

(4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31-(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,22-bis(hydroxymethyl)-10,37,43-tris(2-methylpropyl)-19-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carboxylic acid CAS 127869-51-6 PubChem CID 16179407

CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)CSSC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)CNC1=O

Naproxen Imp. G (EP); Naproxen USP Related Compound G; Naproxen USP RC G; (2R)-2-(6-Methoxynaphthalen-2-yl)propanoic Acid; R-Naproxen; (alphaR)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid; 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (R)- (8CI); (-)-(R)-2-(6-Methoxy-2-naphthyl)propionic acid; (-)-2-(6-Methoxy-2-naphthyl)propionic acid; (-)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid; (-)-Naproxen; (R)-(-)-Naproxen; (R)-2-(6-Methoxy-2-naphthyl)propionic acid; (R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid; (R)-Naproxen; (alphaR)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid; l-Naproxen; Naproxen Related Compound G; Naproxen Impurity G CAS 23979-41-1 PubChem CID 169118

COc1ccc2cc([C@@H](C)C(=O)O)ccc2c1

Losartan Potassium Imp. D (EP); Losartan Imp. D (EP); Losartan USP Related Compound A; Losartan USP RC A; 2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde; Losartan Related Compound A; Losartan Potassium Impurity D; Losartan Impurity D CAS 83857-96-9 PubChem CID 55176

CCCCc1nc(C=O)c(Cl)[nH]1

(17R)-4'-Chloro-5'-ethyl-9-fluoro-11ss-hydroxy-16ss-methylspiro[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione; Clobetasol Propionate 17a-spiro Compound; (17R)-4'-Chloro-5'-ethyl-9-fluoro-11beta-hydroxy-16beta-methylspiro[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione; Clobetasol Propionate 17alpha-spiro Compound; 9a-Fluoro-11b-hydroxy-16b-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3'(2'H)-one; USP Clobetasol propionate Related Compound A; Ph Eur Clobetasol Propionate Impurity J; CCI18747; CCI6990; Clobetasol-17-propionate; CCI1822; Clobetasol-17-propionate isomer; 21-desoxybetamethasone-17-propionate; 16-ene; Ethylenic acid; USP Clobetasol propionate Related Compound A CAS 1486466-31-2 PubChem CID 71312559

CCC1=C(Cl)C(=O)[C@@]2(O1)[C@@H](C)C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C

Benzenepropanamine, N-methyl-?-(4-methylphenoxy)-, hydrochloride (1:1); Benzenepropanamine, N-methyl-?-(4-methylphenoxy)-, hydrochloride (9CI); N-Methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride; Atomoxetine Related Compound C; p-Methyl atomoxetine hydrochloride CAS 873310-31-7 PubChem CID 11644995

CNCCC(Oc1ccc(C)cc1)c1ccccc1.Cl

Pyrimidine, 2-(1-piperazinyl)-; 1-(2-Pyrimidinyl)piperazine; 1-(2-Pyrimidyl)piperazine; 1-(4-Pyrimidin-2-yl)piperazine; 1-PP; 2-(1-Piperazinyl)pyrimidine; 2-Piperazinopyrimidine; 4-(2-Pyrimidinyl)piperazine; CM 56324H; MJ 13653; N-2-Pyrimidinylpiperazine; PmP CAS 20980-22-7 PubChem CID 88747

c1cnc(N2CCNCC2)nc1

3-Methyl-1-phenyl-2-pyrazolin-5-one, 98%, a strong novel free radical scavenger - 100G 100g CAS 89-25-8 PubChem CID 4021

CC1=NN(c2ccccc2)C(=O)C1

Oxalic Acid; Ethanedioic acid; Oxalic acid; Aktisal; Aquisal; DeerClean; NSC 132055; NSC 151956; NSC 62774; NSC 76990; Ultraplast Activate S 52; Oxaliplatin Related Compound A; Ascorbic Acid Impurity E; Sodium Ascorbate Impurity E CAS 144-62-7 PubChem CID 971

O=C(O)C(=O)O

Bis(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,18,18,18-dotriacontafluoro-17-(trifluoromethyl)octadecyl) hydrogen phosphate, compound with 2,2'-iminodiethanol (1:1) CAS 93776-31-9 PubChem CID 56843566

O=P(O)(OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(C(F)(F)F)C(F)(F)F)OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(C(F)(F)F)C(F)(F)F.OCCNCCO

3-Amino-1H-pyrazole-4-carboxamide; 3-Amino-4-carbamoylpyrazole; 3-Amino-4-pyrazolecarboxamide; NSC 1402; Allopurinol EP Impurity A CAS 5334-31-6 PubChem CID 79254

NC(=O)c1cn[nH]c1N

2-(Phenyl)-4-(3-hydroxy-4-chlorophenyl)-5-(4-pyridyl)-1H-imidazole CAS 303727-31-3 PubChem CID 9950176

Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl

1-[2-[4-(4-Fluorophenyl)-3-(trifluoromethyl)phenyl]-1,3-benzoxazol-5-yl]piperidine-4-carboxylic acid PubChem CID 137385109

O=C(O)C1CCN(c2ccc3oc(-c4ccc(-c5ccc(F)cc5)c(C(F)(F)F)c4)nc3c2)CC1

9H-Purin-2-amine, 6-chloro-; 1H-Purin-2-amine, 6-chloro- (9CI); Purine, 2-amino-6-chloro- (6CI,7CI,8CI); 6-Chloro-9H-purin-2-amine; 2-Amino-6-chloro-9H-purine; 2-Amino-6-chloropurine; 6-Chloro-1H-purin-2-amine; 6-Chloro-2-aminopurine; 6-Chloro-2-purinamine; 6-Chloro-7H-purin-2-amine; 6-Chloro-7H-purin-2-ylamine; 6-Chloro-9H-purin-2-yl-2-amine; 6-Chloroguanine; NSC 29570; SKF-17831; 380U58; Nelarabine related; Famciclovir Related Compound F CAS 10310-21-1 PubChem CID 5360349

Nc1nc(Cl)c2[nH]cnc2n1

Chromate(1-), bis[4-(hydroxy-.kappa.O)-3-[2-[2-(hydroxy-.kappa.O)-1-naphthalenyl]diazenyl-.kappa.N1]-N-(1-methylethyl)benzenesulfonamidato(2-)]-, hydrogen, compd. with 2-propanamine (1:1:1) CAS 71566-31-9 PubChem CID 172841

CC(C)N.CC(C)NS(=O)(=O)c1ccc([O-])c(N=Nc2c([O-])ccc3ccccc23)c1.CC(C)NS(=O)(=O)c1ccc([O-])c(N=Nc2c([O-])ccc3ccccc23)c1.[Cr+3].[H+]

1 inverted exclamation marka,3 inverted exclamation marka-Dihydro-8-methoxy-1 inverted exclamation marka,3 inverted exclamation marka,3 inverted exclamation marka-trimethylspiro[2H-1-benzopyran-2,2 inverted exclamation marka-[2H]indole] CAS 13433-31-3 PubChem CID 2841117

COc1cccc2c1OC1(C=C2)N(C)c2ccccc2C1(C)C

Diphenylcarbamic Chloride; Temozolomide Related Compound C (USP); Temozolomide Related Compound C CAS 83-01-2 PubChem CID 65741

O=C(Cl)N(c1ccccc1)c1ccccc1

Valaciclovir Hydrochloride Imp. E (EP); Valaciclovir Imp. E (EP); Valacyclovir USP Related Compound E; Valacyclovir USP RC E; L-Valine, N-[(phenylmethoxy)carbonyl]-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester; GW 327605X; USP Valacyclovir Related Compound E; Ph Eur Valaciclovir Impurity E; Valacyclovir Related Compound E; Valaciclovir Hydrochloride Impurity E; Valaciclovir Impurity E CAS 124832-31-1 PubChem CID 135467921

CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)OCCOCn1cnc2c(=O)[nH]c(N)nc21

(2R,3S,5R)-5-(4-Amino-2-oxo-1,3,5-triazin-1(2H)-yl)-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate CAS 1034301-08-0 PubChem CID 45256853

Nc1ncn([C@H]2C[C@H](OC(=O)c3ccc(Cl)cc3)[C@@H](COC(=O)c3ccc(Cl)cc3)O2)c(=O)n1

[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate; 2-[(2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole CAS 6693-90-9 PubChem CID 72077

CC(C)c1ccccc1OCC1=NCCN1.C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)(O)O

Compound Database